Cargando…
Genetic deletion of IL-25 (IL-17E) confers resistance to dextran sulfate sodium-induced colitis in mice
BACKGROUND: IL-25 is emerging as a key regulator of inflammation in the intestinal mucosa because of its ability to promote type 2 while suppressing Th1 and Th17 responses. Several previous studies reported inconsistent results on the role of exogenous IL-25 in development of colonic inflammation an...
Autores principales: | Wang, An-Jiang, Smith, Allen, Li, Yanfei, Urban, Joseph F, Ramalingam, Thirumalai R, Wynn, Thomas A, Lu, Nonghua, Shea-Donohue, Terez, Yang, Zhonghan, Zhao, Aiping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4417544/ https://www.ncbi.nlm.nih.gov/pubmed/25937893 http://dx.doi.org/10.1186/2045-3701-4-72 |
Ejemplares similares
-
Macrophages as IL-25/IL-33-Responsive Cells Play an Important Role in the Induction of Type 2 Immunity
por: Yang, Zhonghan, et al.
Publicado: (2013) -
Differential dose effects of recombinant IL-25 on the development of dextran sulfate sodium-induced colitis
por: Salum Mchenga, S. S., et al.
Publicado: (2010) -
IL-25 Treatment Improves Metabolic Syndrome in High-Fat Diet and Genetic Models of Obesity
por: Smith, Allen D, et al.
Publicado: (2021) -
Thymopentin ameliorates dextran sulfate sodium-induced colitis by triggering the production of IL-22 in both innate and adaptive lymphocytes
por: Cao, Qiuhua, et al.
Publicado: (2019) -
The protective effect of IL‐12/23 neutralizing antibody in sarcopenia associated with dextran sulfate sodium‐induced experimental colitis
por: Jung, Youn‐Kwan, et al.
Publicado: (2023)